nach oben

Erschienen in:

01.01.2010 | Original Contribution

Humoral anti-proteasomal autoimmunity in dilated cardiomyopathy

verfasst von: Antje Voigt, Katrin Bartel, Karl Egerer, Christiane Trimpert, Eugen Feist, Christine Gericke, Reinhard Kandolf, Karin Klingel, Ulrike Kuckelkorn, Karl Stangl, Stephan B. Felix, Gert Baumann, Peter-M. Kloetzel, Alexander Staudt

Erschienen in: Basic Research in Cardiology | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Virus-induced chronic inflammation, autoimmune processes and impaired protein quality control may be involved in the pathogenesis of dilated cardiomyopathy (DCM). The ubiquitin–proteasome system is important in the modulation of inflammatory processes and the immune response. Proteasomes were identified as targets of a humoral autoimmune response in systemic inflammatory diseases, which provoked us to investigate anti-proteasomal immunity in DCM in detail: a total of 90 DCM patients with impaired left-ventricular function (LVEF ≤ 45%) were enrolled in this study. Autoimmune response to cardiac proteasomes was found to be enhanced in DCM patients, revealing the detection of predominantly α subunits of the 20S proteasome complex. Proteasome antibody (ProtAb) levels were found to be particularly enhanced at stages of advanced heart failure: moderately decreased LVEF and considerably increased NT-pro BNP levels were observed in DCM patients who tested positive for ProtAb (P < 0.05). A linear regression model suggested a link between the detection of cardiotropic viruses in endomyocardial biopsies and anti-proteasomal immunity (P < 0.01). Likewise, ProtAb levels were enhanced in a murine model of chronic enterovirus myocarditis. Our data also point to a potential interaction of ProtAb with the cell surface: ProtAb exerted negative inotropic effects in field-stimulated cardiomyocytes. In conclusion, humoral autoreactive anti-proteasome immune responses appear to be enhanced in DCM. Viral infection of the myocardium may be linked to the induction of anti-proteasomal immunity in DCM.

Arribas J, Rodriguez ML, Forno RAD, Castano JG (1991) Autoantibodies against the multicatalytic proteinase in patients with systemic lupus-erythematosus. J Exp Med 173:423–427CrossRefPubMed

Avcin T, Canova M, Guilpain P, Guillevin L, Kallenberg CGM, Tincani A, Tonon M, Zampieri S, Doria A (2008) Infections, connective tissue diseases and vasculitis. Clin Exp Rheumatol 26:S18–S26PubMed

Brychcy M, Kuckelkorn U, Hausdorf G, Egerer K, Kloetzel PM, Burmester GR, Feist E (2006) Anti-20S proteasome autoantibodies inhibit proteasome stimulation by proteasome activator PA28. Arthritis Rheum 54:2175–2183CrossRefPubMed

Bureau JP, Olink-Coux M, Brouard N, Bayle-Julien S, Huesca M, Herzberg M, Scherrer K (1997) Characterization of prosomes in human lymphocyte subpopulations and their presence as surface antigens. Exp Cell Res 231:50–60CrossRefPubMed

Buvall L, Bollano E, Chen J, Shultze W, Fu M (2006) Phenotype of early cardiomyopathic changes induced by active immunization of rats with a synthetic peptide corresponding to the second extracellular loop of the human beta(1)-adrenergic receptor. Clin Exp Immunol 143:209–215CrossRefPubMed

Caforio AL, Tona F, Bottaro S, Vinci A, Dequal G, Daliento L, Thiene G, Iliceto S (2008) Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Autoimmunity 41:35–45CrossRefPubMed

Caforio ALP, Calabrese F, Angelini A, Tona F, Vinci A, Bottaro S, Ramondo A, Carturan E, Iliceto S, Thiene G, Daliento L (2007) A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 28:1326–1333CrossRefPubMed

Caforio ALP, Grazzini M, Mann JM, Keeling PJ, Bottazzo GF, McKenna WJ, Schiaffino S (1992) Identification of alpha-cardiac and beta-cardiac myosin heavy-chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 85:1734–1742PubMed

Caforio ALP, Mahon NJ, McKenna WJ (2001) Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy. Autoimmunity 34:199–204PubMedCrossRef

10.

de Groote P, Dagorn J, Soudan B, Lamblin N, McFadden E, Bauters C (2004) B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. J Am Coll Cardiol 43:1584–1589CrossRefPubMed

11.

Feist E, Dorner T, Kuckelkorn U, Scheffler S, Burmester GR, Kloetzel PM (2000) Diagnostic importance of anti-proteasome antibodies. Int Arch Allergy Immunol 123:92–97CrossRefPubMed

12.

Feist E, Dorner T, Kuckelkorn U, Schmidtke G, Micheel B, Hiepe F, Burmester GR, Kloetzel PM (1996) Proteasome alpha-type subunit C9 is a primary target of autoantibodies in sera of patients with myositis and systemic lupus erythematosus. J Exp Med 184:1313–1318CrossRefPubMed

13.

Feist E, Kuckelkorn U, Dorner T, Donitz H, Scheffler S, Hiepe F, Kloetzel PM, Burmester GR (1999) Autoantibodies in primary Sjogren’s syndrome are directed against proteasomal subunits of the alpha and beta type. Arthritis Rheum 42:697–702CrossRefPubMed

14.

Felix SB, Staudt A, Landsberger M, Grosse Y, Stangl V, Spielhagen T, Wallukat G, Wernecke KD, Baumann G, Stangl K (2002) Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. J Am Coll Cardiol 39:646–652CrossRefPubMed

15.

Gomes AV, Zong C, Edmondson RD, Li X, Stefani E, Zhang J, Jones RC, Thyparambil S, Wang GW, Qiao X, Bardag-Gorce F, Ping PP (2006) Mapping the murine cardiac 26S proteasome complexes. Circ Res 99:362–371CrossRefPubMed

16.

Groll M, Bajorek M, Kohler A, Moroder L, Rubin DM, Huber R, Glickman MH, Finley D (2000) A gated channel into the proteasome core particle. Nat Struct Biol 7:1062–1067CrossRefPubMed

17.

Harris JR (1968) Release of a macromolecular protein component from human erythrocyte ghosts. Biochim Biophys Acta 150:534–537CrossRefPubMed

18.

Harris JR (1969) Isolation and purification of a macromolecular protein component from human erythrocyte ghost. Biochim Biophys Acta 188:31–42PubMed

19.

Herrmann J, Soares SM, Lerman LO, Lerman A (2008) Potential role of the ubiquitin–proteasome system in atherosclerosis. J Am Coll Cardiol 51:2003–2010CrossRefPubMed

20.

Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, Lohse MJ (2004) Direct evidence for a beta(1)-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 113:1419–1429PubMed

21.

Jahns R, Boivin V, Siegmund C, Inselmann G, Lohse MJ, Boege F (1999) Autoantibodies activating human beta(1)-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 99:649–654PubMed

22.

Jäkel S, Kuchelkorn U, Szalay G, Plötz M, Textoris-Taube K, Opitz E, Klingel K, Stevanovic S, Kandolf R, Kotsch K, Stangl K, Kloetzel PM, Voigt A (2009) Differential interferon responses enhance viral epitope generation by myocardial immunoproteasomes in murine enterovirus myocarditis. Am J Pathol 175(2):510–518CrossRefPubMed

23.

Jakob C, Egerer K, Liebisch P, Turkmen S, Zavrski I, Kuckelkorn U, Heider U, Kaiser M, Fleissner C, Sterz J, Kleeberg L, Feist E, Burmester GR, Kloetzel PM, Sezer O (2007) Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma. Blood 109:2100–2105CrossRefPubMed

24.

Kindermann I, Kindermann M, Kandolf R, Klingel K, Bultmann B, Muller T, Lindinger A, Bohm M (2008) Predictors of outcome in patients with suspected myocarditis. Circulation 118:639–648CrossRefPubMed

25.

Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, Kandolf R (1992) Ongoing enterovirus-induced myocarditis is associated with persistent heart-muscle infection—quantitative-analysis of virus-replication, tissue-damage, and inflammation. Proc Natl Acad Sci USA 89:314–318CrossRefPubMed

26.

Kloetzel PM (2001) Antigen processing by the proteasome. Nat Rev Mol Cell Biol 2:179–187CrossRefPubMed

27.

Kuhl U, Melzner B, Schafer B, Schultheiss HP, Strauer BE (1991) The Ca-channel as cardiac autoantigen. Eur Heart J 12:99–104PubMed

28.

Kuhl U, Noutsias M, Seeberg B, Schultheiss HP (1996) Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart 75:295–300CrossRefPubMed

29.

Kuhl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP (2005) High prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction. Circulation 111:887–893CrossRefPubMed

30.

Kuhl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HPP (2005) Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112:1965–1970CrossRefPubMed

31.

Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Bock CT, Klingel K, Kandolf R, Sechtem U (2006) Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114:1581–1590CrossRefPubMed

32.

Matsui S, Larsson L, Hayase M, Katsuda S, Teraoka K, Kurihara T, Murano H, Nishikawa K, Fu M (2006) Specific removal of beta 1-adrenoceptor autoantibodies by immunoabsorption in rabbits with autoimmune cardiomyopathy improved cardiac structure and function. J Mol Cell Cardiol 41:78–85CrossRefPubMed

33.

Noutsias M, Seeberg B, Schultheiss HP, Kuhl U (1999) Expression of cell adhesion molecules in dilated cardiomyopathy—evidence for endothelial activation in inflammatory cardiomyopathy. Circulation 99:2124–2131PubMed

34.

Pankuweit S, Portig I, Lottspeich F, Maisch B (1997) Autoantibodies in sera of patients with myocarditis: characterization of the corresponding proteins by isoelectric focusing and N-terminal sequence analysis. J Mol Cell Cardiol 29:77–84CrossRefPubMed

35.

Patterson C, Ike C, Willis PW, Stouffer GA, Willis MS (2007) The bitter end: the ubiquitin–proteasome system and cardiac dysfunction. Circulation 115:1456–1463CrossRefPubMed

36.

Powell SR (2006) The ubiquitin–proteasome system in cardiac physiology and pathology. Am J Physiol Heart Circ Physiol 291:H1–H19CrossRefPubMed

37.

Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P (1996) Report of the 1995 World Health Organization International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93:841–842PubMed

38.

Rivett AJ, Palmer A, Knecht E (1992) Electron-microscopic localization of the multicatalytic proteinase complex in rat-liver and in cultured-cells. J Histochem Cytochem 40:1165–1172PubMed

39.

Rose NR, Bona C (1993) Defining criteria for autoimmune-diseases (Witebsky postulates revisited). Immunol Today 14:426–429CrossRefPubMed

40.

Schwimmbeck PL, Bigalke B, Schulze K, Pauschinger M, Kuhl U, Schultheiss HP (2004) The humoral immune response in viral heart disease: characterization and pathophysiological significance of antibodies. Med Microbiol Immunol 193:115–119CrossRefPubMed

41.

Sixt SU, Dahlmann B (2008) Extracellular, circulating proteasomes and ubiquitin—incidence and relevance. Biochim Biophys Acta 1782:817–823PubMed

42.

Staudt A, Eichler P, Trimpert C, Felix SB, Greinacher A (2007) Fc(gamma) receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy. J Am Coll Cardiol 49:1684–1692CrossRefPubMed

43.

Staudt A, Staudt Y, Dorr M, Bohm M, Knebel F, Hummel A, Wunderle L, Tiburcy M, Wernecke KD, Baumann G, Felix SB (2004) Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy. J Am Coll Cardiol 44:829–836CrossRefPubMed

44.

Szalay G, Meiners S, Voigt A, Lauber J, Spieth C, Speer N, Sauter M, Kuckelkorn U, Zell A, Klingel K, Stangl K, Kandolf R (2006) Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes. Am J Pathol 168:1542–1552CrossRefPubMed

45.

Szalay G, Sauter M, Hald J, Weinzierl A, Kandolf R, Klingel K (2006) Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders. Am J Pathol 169:2085–2093CrossRefPubMed

46.

Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, Ohnishi M, Sugimoto Y, Kinoshita M (1997) Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure—prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96:509–516PubMed

47.

Weekes J, Morrison K, Mullen A, Wait R, Barton P, Dunn MJ (2003) Hyperubiquitination of proteins in dilated cardiomyopathy. Proteomics 3:208–216CrossRefPubMed

48.

Wessely R, Klingel K, Santana LF, Dalton N, Hongo M, Lederer WJ, Kandolf R, Knowlton KU (1998) Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation–contraction coupling and dilated cardiomyopathy. J Clin Invest 102:1444–1453CrossRefPubMed

49.

Young GW, Wang YJ, Ping PP (2008) Understanding proteasome assembly and regulation: importance to cardiovascular medicine. Trends Cardiovasc Med 18:93–98CrossRefPubMed

50.

Zong C, Gomes AV, Drews O, Li XH, Young GW, Berhane B, Qiao X, French SW, Bardag-Gorce F, Ping PP (2006) Regulation of murine cardiac 20S proteasomes—role of associating partners. Cir Res 99:372–380CrossRef

Titel: Humoral anti-proteasomal autoimmunity in dilated cardiomyopathy
verfasst von: Antje Voigt
Katrin Bartel
Karl Egerer
Christiane Trimpert
Eugen Feist
Christine Gericke
Reinhard Kandolf
Karin Klingel
Ulrike Kuckelkorn
Karl Stangl
Stephan B. Felix
Gert Baumann
Peter-M. Kloetzel
Alexander Staudt
Publikationsdatum: 01.01.2010
Verlag: D. Steinkopff-Verlag
Erschienen in: Basic Research in Cardiology / Ausgabe 1/2010
Print ISSN: 0300-8428
Elektronische ISSN: 1435-1803
DOI: https://doi.org/10.1007/s00395-009-0061-z

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Humoral anti-proteasomal autoimmunity in dilated cardiomyopathy

Abstract

Neu im Fachgebiet Kardiologie

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Darf man die Behandlung eines Neonazis ablehnen?

Update Kardiologie

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2010

Sonic hedgehog is a potent chemoattractant for human monocytes: diabetes mellitus inhibits Sonic hedgehog-induced monocyte chemotaxis

Effects of muscarinic receptor stimulation on Ca2+ transient, cAMP production and pacemaker frequency of rabbit sinoatrial node cells

Multi-slice computed tomography with N1177 identifies ruptured atherosclerotic plaques in rabbits

Blockade of NF-κB by pyrrolidine dithiocarbamate attenuates myocardial inflammatory response and ventricular dysfunction following coronary microembolization induced by homologous microthrombi in rats

Transcriptional and posttranscriptional regulators of biglycan in cardiac fibroblasts

Role of autoimmunity in dilated cardiomyopathy

Neu im Fachgebiet Kardiologie

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Darf man die Behandlung eines Neonazis ablehnen?

Update Kardiologie